Publicacions (53) Publicacions en què ha participat algun/a investigador/a

2024

  1. Using C. elegans as a model for neurodegenerative diseases: Methodology and evaluation

    Methods in Cell Biology (Academic Press Inc.), pp. 1-34

2023

  1. Arrhythmic Effects Evaluated on Caenorhabditis elegans: The Case of Polypyrrole Nanoparticles

    ACS Nano, Vol. 17, Núm. 17, pp. 17273-17284

  2. Enhanced Mitochondria-SR Tethering Triggers Adaptive Cardiac Muscle Remodeling

    Circulation Research, Vol. 132, Núm. 11, pp. E171-E187

  3. Measurements of Calcium in Chromaffin Cell Organelles Using Targeted Aequorins

    Methods in molecular biology (Clifton, N.J.), Vol. 2565, pp. 153-177

  4. Mitochondrial Ca2+ signaling and Alzheimer's disease: Too much or too little?

    Cell Calcium, Vol. 113

  5. SERCA inhibition improves lifespan and healthspan in a chemical model of Parkinson disease in Caenorhabditis elegans

    Frontiers in Pharmacology, Vol. 14

  6. SLC25A46 promotes mitochondrial fission and mediates resistance to lipotoxic stress in INS-1E insulin-secreting cells

    Journal of Cell Science, Vol. 136, Núm. 8

  7. The mitochondrial calcium uniporter (MCU) activates mitochondrial respiration and enhances mobility by regulating mitochondrial redox state

    Redox Biology, Vol. 64

2022

  1. Mitochondrial respiratory chain dysfunction alters ER sterol sensing and mevalonate pathway activity

    Journal of Biological Chemistry, Vol. 298, Núm. 3

  2. Modeling Alzheimer’s Disease in Caenorhabditis elegans

    Biomedicines, Vol. 10, Núm. 2

2021

  1. Healthcare data for achieving a more personalized treatment of chronic kidney disease

    Biomedicines

  2. Mechanism of the lifespan extension induced by submaximal SERCA inhibition in C. elegans

    Mechanisms of Ageing and Development, Vol. 196

  3. Mitochondrial ion channels in pancreatic β-cells: Novel pharmacological targets for the treatment of Type 2 diabetes

    British Journal of Pharmacology, Vol. 178, Núm. 10, pp. 2077-2095

  4. The Mitochondrial Na+/Ca2+ Exchanger Inhibitor CGP37157 Preserves Muscle Structure and Function to Increase Lifespan and Healthspan in Caenorhabditis elegans

    Frontiers in Pharmacology, Vol. 12

2020

  1. Clinical profile, treatment and predictors during the first covid-19 wave: A population-based registry analysis from castile and leon hospitals

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 24, pp. 1-15

  2. Mitochondrial Ca2+ dynamics in MCU knockout C. Elegans worms

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-11

  3. Population-based registry analysis of antidiabetics dispensations: Trend use in Spain between 2015 and 2018 with reference to driving

    Pharmaceuticals, Vol. 13, Núm. 8, pp. 1-12

  4. The Role of Ca2+ Signaling in Aging and Neurodegeneration: Insights from Caenorhabditis elegans Models

    Cells, Vol. 9, Núm. 1

2019

  1. Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release from the endoplasmic reticulum by AMP-activated kinase modulators

    Cell Calcium, Vol. 77, pp. 68-76

  2. The neuroprotector benzothiazepine CGP37157 extends lifespan in C. Elegans Worms

    Frontiers in Aging Neuroscience, Vol. 11, Núm. JAN